PharmaCorp Announces Supplemental Listing of Warrants

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SASKATOON, Saskatchewan, Nov. 13, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce that it has received approval of the TSX Venture Exchange (the “TSXV”) for the supplemental listing of 27,427,500 common share purchase warrants of the Company (the “Warrants”) issuable pursuant to the Company’s previously announced prospectus offering (the “Offering”) of units of the Company (“Units”). The Warrants are expected to be listed for trading on the TSXV effective as of the opening of markets on November 17, 2025 under the symbol PCRX.WT.

Read more at globenewswire.com